BMS mezigdomide, iberdomide to transform multiple myeloma treatment landscape: GlobalData
The sales for mezigdomide and iberdomide are predicted to reach $125 million and $389 million, respectively
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.